RADNET, Inc. (NASDAQ:RDNT) Files An 8-K Results of Operations and Financial Condition
Item 2.02
(d) Exhibits
RADNET, Inc. (NASDAQ:RDNT) Files An 8-K Results of Operations and Financial Condition
Item 2.02
(d) Exhibits
RadNet, Inc. Exhibit
EX-99.1 2 radnet_ex9901.htm PRESS RELEASE DATED MARCH 12,…
To view the full exhibit click here
About RADNET, Inc. (NASDAQ:RDNT)
RadNet, Inc. is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. The Company operates directly or indirectly through joint ventures with hospitals, approximately 300 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. It operates approximately 140 fixed-site, freestanding outpatient diagnostic imaging facilities in California, over 10 in Delaware, three in Florida, 50 in Maryland, 20 in New Jersey, 20 in the Rochester and Hudson Valley areas of New York, approximately 40 in New York City, as well as five in Rhode Island.